TY  - CONF

T1  - Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response

JO  - Annals of Oncology

PY  - 2000/01/01

AU  - Foran JM

AU  - Cunningham D

AU  - Coiffier B

AU  - Solal-Celigny P

AU  - Reyes F

AU  - Ghielmini M

AU  - Johnson PWM

AU  - Gisselbrecht C

AU  - Bradburn M

AU  - Matthews J

AU  - Lister TA

ED  - 

DO  - DOI: 10.1093/annonc/11.suppl_1.s117

PB  - Elsevier BV

VL  - 11

SP  - S117

EP  - S121

Y2  - 2024/12/22

ER  -